Can a scotoma be a sign of ocular (retinal) migraine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Scotoma Be a Sign of Ocular (Retinal) Migraine?

Yes, scotoma is a defining feature of retinal migraine—it presents as monocular visual disturbance including scotomas, flashes, or blindness that is fully reversible and associated with migraine headache within 60 minutes of visual symptom onset 1, 2.

Understanding the Clinical Presentation

Retinal migraine is distinct from the more common migraine with aura. While typical migraine aura causes bilateral visual symptoms (fortification spectra in >90% of cases) 3, retinal migraine specifically causes monocular visual loss 2. The key diagnostic features include:

  • Monocular scotomas (partial visual field loss in one eye only)
  • Flashes or scintillations affecting only one eye
  • Complete monocular blindness in severe cases
  • Symptoms lasting less than 1 hour
  • Associated migraine headache within 60 minutes of visual symptoms 1, 2

Critical Diagnostic Considerations

Retinal migraine is a diagnosis of exclusion—you must rule out other causes of transient monocular visual loss before making this diagnosis 2. This is crucial because:

  • Nearly half of patients with recurrent transient monocular visual loss subsequently experience permanent monocular visual loss 4
  • Despite current diagnostic criteria requiring fully reversible symptoms, irreversible visual loss is part of the retinal migraine spectrum 4
  • Retinal microvascular alterations can predispose to retinal ischemia 5

Essential Workup to Exclude:

  • Retinal artery/vein occlusions (requires fundoscopic exam, OCT imaging)
  • Acute macular neuroretinopathy (AMN)—presents with paracentral scotoma in young women 6
  • Paracentral acute middle maculopathy (PAMM)
  • Embolic phenomena (carotid disease, cardiac sources)
  • Giant cell arteritis (if age >50 years)
  • Retinal detachment or other structural pathology

When Scotoma Suggests Typical Migraine Aura vs. Retinal Migraine

If the scotoma is bilateral or affects both visual fields simultaneously, this represents typical migraine with visual aura, not retinal migraine 3. Visual aura in typical migraine:

  • Affects both eyes (bilateral visual field involvement)
  • Presents as fortification spectra most commonly
  • Can include sensory symptoms (31% have paresthesias) 3

If the scotoma is strictly monocular (cover one eye and symptoms persist only in the affected eye), consider retinal migraine but investigate thoroughly for other causes first.

Important Clinical Pitfalls

  1. The term "ocular migraine" is problematic—it has been used interchangeably with retinal migraine in literature, creating confusion 2. Use the specific term "retinal migraine" per ICHD-3 criteria.

  2. Retinal migraine can occur without headache (acephalgic variant), making diagnosis even more challenging 7. The absence of headache does not exclude the diagnosis if other criteria are met.

  3. Don't assume all visual symptoms are benign—documented visual field defects on computerized testing have been reported 1, and persistent deficits can occur despite the "fully reversible" criterion 4.

  4. Multimodal imaging is essential—OCT is the preferred technique to identify retinal layer abnormalities that may indicate alternative diagnoses like AMN 6.

Management Approach

Once retinal migraine is confirmed as a diagnosis of exclusion:

  • Low-dose aspirin may be considered to decrease risk of permanent visual loss 7
  • Standard migraine preventive therapy if attacks are frequent (≥2 days/month affecting quality of life) 3
  • Acute treatment follows standard migraine protocols: NSAIDs first-line, triptans second-line 3
  • Note: Triptans should NOT be used during the visual symptom phase 3

The critical message: Any monocular scotoma requires urgent ophthalmologic evaluation to exclude sight-threatening conditions before attributing it to retinal migraine 2.

References

Research

Current Perspective on Retinal Migraine.

Vision (Basel, Switzerland), 2021

Guideline

diagnosis and management of migraine in ten steps.

Nature Reviews Neurology, 2021

Research

Retinal migraine.

Handbook of clinical neurology, 2024

Research

Acute macular neuroretinopathy associated with migraine.

Archivos de la Sociedad Espanola de Oftalmologia, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.